Use of an Anti-Low Density Lipoprotein Receptor Antibody to Quantify the Role of the LDL Receptor in the Removal of Chylomicron Remnants in the Mouse in Vivo.
Journal of Clinical Investigation - United States
doi 10.1172/jci115419
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 1991
Authors
Publisher
American Society for Clinical Investigation